These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Some clinical experiences with the arylsulfonylureas in the management of diabetes mellitus. ERK V; HAAR H; MCGAVACK TH; SEEGERS W Metabolism; 1956 Nov; 5(6 Part 2):919-32. PubMed ID: 13378061 [No Abstract] [Full Text] [Related]
18. [BZ 55 of D 860 as oral antidiabetic]. MEHNERT B; MEHNERT H Munch Med Wochenschr; 1956 Sep; 98(39):1325-8. PubMed ID: 13378442 [No Abstract] [Full Text] [Related]
19. Methods of selection of diabetic patients sensitive to sulfonylurea compounds. DUNCAN GG; JOINER CL; LEE CT Metabolism; 1956 Nov; 5(6 Part 2):964-71. PubMed ID: 13378066 [No Abstract] [Full Text] [Related]
20. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)]. BERTRAM F Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958 [No Abstract] [Full Text] [Related] [Next] [New Search]